Satsuma Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch STSA and buy or sell other stocks, ETFs, and their options commission-free!About STSA
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraines.
CEORyoichi Nagata, MD, PhD
CEORyoichi Nagata, MD, PhD
Employees—
Employees—
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2016
Founded2016
Employees—
Employees—
STSA Key Statistics
Market cap36.47M
Market cap36.47M
Price-Earnings ratio-0.55
Price-Earnings ratio-0.55
Dividend yield—
Dividend yield—
Average volume412.49K
Average volume412.49K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.08
52 Week high$8.08
52 Week low$0.59
52 Week low$0.59
Stock Snapshot
Satsuma Pharmaceuticals(STSA) stock is priced at $1.10, giving the company a market capitalization of 36.47M. It carries a P/E multiple of -0.55.
Satsuma Pharmaceuticals(STSA) stock opened on 2025-12-08 at —. The price climbed to — and dipped to —.
Satsuma Pharmaceuticals(STSA) shares are trading with a volume of 0, against a daily average of 412.49K.
In the last year, Satsuma Pharmaceuticals(STSA) shares hit a 52-week high of $8.08 and a 52-week low of $0.59.
In the last year, Satsuma Pharmaceuticals(STSA) shares hit a 52-week high of $8.08 and a 52-week low of $0.59.
People also own
Based on the portfolios of people who own STSA. This list is generated using Robinhood data, and it’s not a recommendation.